ALBION FINANCIAL GROUP /UT
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1054677
SALT LAKE CITY, UT
Position in TMO
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$11,957,941
-$2,180,639 QoQ
Shares Held
24,328
-0.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
22 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026ALBION FINANCIAL GROUP /UT holds $13,117,631 across 9 Diagnostics & Research names. TMO ranks #1 (91.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
24,328 | $11,957,941 | |
| 2 | A |
Agilent Technologies, Inc.
|
7,826 | $892,007 | |
| 3 | DHR |
Danaher Corp /De/
|
1,290 | $244,584 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
26 | $14,609 | |
| 5 | WAT |
Waters Corp /De/
|
15 | $4,467 | |
| 6 | DGX |
Quest Diagnostics Inc
|
11 | $2,155 | |
| 7 | LH |
Labcorp Holdings Inc.
|
6 | $1,600 | |
| 8 | ILMN |
Illumina, Inc.
|
2 | $246 |
All Filings in TMO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,957,941 | 24,328 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $14,138,580 | 24,400 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $12,140,050 | 25,030 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $10,333,959 | 25,487 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $12,723,632 | 25,570 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $13,361,587 | 25,684 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $16,121,171 | 26,062 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $14,375,235 | 25,995 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $15,214,334 | 26,177 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $13,963,492 | 26,307 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $13,300,629 | 26,277 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $13,520,107 | 25,913 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $15,609,252 | 27,082 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $15,294,313 | 27,773 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $14,042,062 | 27,686 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $15,073,303 | 27,745 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $16,208,617 | 27,442 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $17,306,203 | 25,937 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $13,879,891 | 24,294 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $12,223,812 | 24,231 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $9,822,368 | 21,088 | Shares | Sole | 2021-02-19 | |
| 2020-09-30 | $6,518,601 | 14,764 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||